Skip to main content
OpenTrials
Completed

NCT Number: NCT07084116

Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin

The purpose of this research is to determine whether once nightly application of tretinoin 0.1% cream to forearm skin reduces the frequency of skin tears and bruising (solar purpura), and changes skin thickness over a period of 6 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

55 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Palo Alto VA Medical Center

Palo Alto, California, 94304, United States

About this study

Easy bruising and tearing of forearm skin is common with aging and can cause activity restriction, infection, and pain. Chronic exposure to UV light from the sun causes skin thinning and loss of supportive collagen over time. Thin skin tears easily and blood vessels normally protected by collagen rupture, causing bruises. Tretinoin is a prescription vitamin A cream that has been shown to increase skin thickness and collagen. Tretinoin is FDA approved for treatment of acne. We are trying to figure out if putting tretinoin cream on the forearms of adults with thin skin prevents skin tears and bruising.

We are looking for 30 people with a history of skin tears in the United States. The VA Palo Alto expects to enroll 30 research study subjects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (55+)
  • History of skin tears, at least 2 in the past month
  • History of skin bruising (solar purpura)
  • Ambulatory
  • Able to apply topical medication to oneself

Exclusion criteria

  • <55 years old)
  • Pregnant or breastfeeding
  • History of allergy to tretinoin
  • History of atopic dermatitis, psoriasis, bullous skin disease, cutaneous lupus, or cutaneous T cell lymphoma.
  • Planned cutaneous surgery on either forearm in the next 6 months
  • Use of any topical medication on the forearms within past month
  • Current or anticipated phototherapy of the forearms in the next 6 months
  • Current or anticipated chemotherapy within the next 6 months
  • Use of oral steroids within past month
  • Current or prior isotretinoin therapy within past 6 months
  • AV fistula of the arm

Treatment and study plan

Tretinoin 0.1% cream

Drug

Tretinoin 0.1% cream formulation.

Other names: Bland cream (non-medicated)

Bland cream (non-drug)

Drug

Bland cream formulation.

Primary outcomes

  1. Change in frequency of skin tears.

    Time frame: 6 months.

  2. Change in epidermal (top layer of skin) thickness.

    Time frame: 6 months.

Secondary outcomes

  1. Change in percent of skin on the arms involved by solar purpura (bruising).

    Time frame: 6 months.

Sponsors and collaborators

Lead sponsor

James Thomas Pathoulas

Other

Registry information

Official study title

Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin: an Open-label Within-subject Randomized Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 24, 2025
Registry last updated
May 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.